Although MT-II has only been studied clinically for its libido-boosting effects in males, an MT-II analog called PT-141 has been researched extensively in women, and it is already approved for therapy in premenopausal women with hypoactive sexual desire disorder (HSDD)
Flegal, K
Plus, focusing on health regardless of body size or weight (i.e
Some clinics use a shorter interval of around seven to ten days for small areas, while others prefer four to six weeks so any swelling fully resolves first
4-7 During midlife, the decreased amount of estrogen in a womans musculoskeletal system results in loss of lean muscle mass, loss of bone density, increased risk of fracture, increased injury to tendons and ligaments, adhesive capsulitis, cartilage matrix fragility leading to osteoarthritis, musculoskeletal pain, and metabolic dysfunction